3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Genitourinary
1
Conditions
Polycystic Ovary Syndrome
139
Breast Neoplasms
31
Prostatic Neoplasms
29
Insulin Resistance
28
Obesity
19
Pancreatic Neoplasms
13
Infertility
12
Endometrial Neoplasms
12
Carcinoma, Non-Small-Cell Lung
12
Neoplasms
11
Colorectal Neoplasms
11
Anovulation
9
Lung Neoplasms
8
Metabolic Syndrome
7
Melanoma
7
Hyperandrogenism
7
Glioblastoma
7
Diabetes Mellitus
7
Squamous Cell Carcinoma of Head and Neck
6
Neoplasm Metastasis
6
Rectal Neoplasms
5
Adenocarcinoma
5
Weight Loss
4
Urinary Bladder Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Head and Neck Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Adenocarcinoma of Lung
4
Uterine Cervical Neoplasms
3
Recurrence
3
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
testosterone undecanoate
1
Sirolimus
1
Nelfinavir
1
Metformin
1
Hydroxychloroquine
1
Gonadotropins
1
Diet, Protein-Restricted
1
Dasatinib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostate Cancer Recurrent
×
Metformin
×
Clear all
NCT05036226
2026-05-13
COAST
Medical University of South Carolina
Phase 1/2
Recruiting
76 enrolled